These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 38782581)

  • 21. A boost to hepatitis B vaccine: no need for boosters.
    Aggarwal R
    Natl Med J India; 2005; 18(6):313-4. PubMed ID: 16483032
    [No Abstract]   [Full Text] [Related]  

  • 22. The changing prevalence of hepatitis B virus infection among men who have sex with men who attended a sexually transmitted infections clinic in Edinburgh, Scotland between 1989 and 2003.
    McMillan A
    Int J STD AIDS; 2006 Aug; 17(8):539-42. PubMed ID: 16925901
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immune response to hepatitis B vaccination in a group of medical students in Sri Lanka.
    Noordeen F; Madushanka DG; Pitchai FN
    Ceylon Med J; 2016 Mar; 61(1):46. PubMed ID: 27031984
    [No Abstract]   [Full Text] [Related]  

  • 24. Sexual behaviors and seroprevalence of HIV, HBV, and HCV among hill tribe youths of Northern Thailand.
    Apidechkul T
    BMC Public Health; 2019 Aug; 19(1):1101. PubMed ID: 31412838
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictive factors for anti-HBs status after 1 booster dose of hepatitis B vaccine.
    Lu IC; Jean MC; Lin CW; Chen WH; Perng DS; Lin CW; Chuang HY
    Medicine (Baltimore); 2016 Sep; 95(39):e5023. PubMed ID: 27684874
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vaccination against hepatitis B in a general hospital in Israel: antibody level before vaccination and immunogenicity of vaccine.
    Karpuch J; Scapa E; Eshchar J; Waron M; Bar-Shany S; Shwartz T
    Isr J Med Sci; 1993 Aug; 29(8):449-52. PubMed ID: 8407270
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Concurrence of hepatitis B surface antigen and antibody in acute and chronic hepatitis B cases.
    Ng KP; Saw TL
    Med J Malaysia; 1994 Jun; 49(2):117-21. PubMed ID: 8090089
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatitis B testing and vaccination among adults with sexually transmitted infections in a large managed care organization.
    Hechter RC; Jacobsen SJ; Luo Y; Nomura JH; Towner WJ; Tartof SY; Tseng HF
    Clin Infect Dis; 2014 Jun; 58(12):1739-45. PubMed ID: 24571863
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes in recreational drug use, drug use associated with chemsex, and HIV-related behaviours, among HIV-negative men who have sex with men in London and Brighton, 2013-2016.
    Sewell J; Cambiano V; Miltz A; Speakman A; Lampe FC; Phillips A; Stuart D; Gilson R; Asboe D; Nwokolo N; Clarke A; Hart G; Rodger A
    Sex Transm Infect; 2018 Nov; 94(7):494-501. PubMed ID: 29700052
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatitis B markers in men seeking human immunodeficiency virus antibody testing in Mexico City.
    Juárez-Figueroa LA; Uribe-Salas FJ; Conde-Glez CJ; Hernández-Avila M; Hernández-Nevárez P; Uribe-Zúñiga P; del Río-Chiriboga C
    Sex Transm Dis; 1997 Apr; 24(4):211-7. PubMed ID: 9101632
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Positive hepatitis B surface antibody is associated with reduced risk of diabetes mellitus in retired female Chinese workers.
    Li M; Zhou H; Guan Y; Peng H; Wang S; Zhang P; Su B
    J Diabetes; 2016 Jan; 8(1):158-61. PubMed ID: 26016384
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The impact of glucose tolerance state on seropositivity rate after hepatitis B vaccination.
    Chang Villacreses MM; Karnchanasorn R; Ou HY; Samoa R; Chuang LM; Chiu KC
    Sci Rep; 2022 Feb; 12(1):3087. PubMed ID: 35197568
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of antibody to hepatitis B core antigen among hepatitis B surface antigen-negative blood donors in Ilorin, Nigeria: A cross-sectional study.
    Ogunfemi MK; Olawumi HO; Olokoba AB; Kagu MB; Biliaminu SA; Durowade KA; Durotoye IA; Shittu AO
    Malawi Med J; 2017 Mar; 29(1):32-36. PubMed ID: 28567194
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatitis B prevalence among workers in Turkey at low risk for hepatitis B exposure.
    Güven R; Ozcebe H; Cakir B
    East Mediterr Health J; 2006 Nov; 12(6):749-57. PubMed ID: 17333819
    [No Abstract]   [Full Text] [Related]  

  • 35. [The importance of early and maternal antibodies to HBsAg in preventing hepatitis B in plasma recipients].
    Sychev AV; Mikhaĭlov MI; Shakhgil'dian IV
    Vopr Virusol; 1990; 35(3):197-9. PubMed ID: 2219850
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High prevalence of anti-hepatitis A IgG in a cohort of UK HIV-negative men who have sex with men: implications for local hepatitis A vaccine policy.
    Bhagey A; Foster K; Ralph S; Wardropper A; White C; Wholey V; Duncan S
    Int J STD AIDS; 2018 Sep; 29(10):1007-1010. PubMed ID: 29743003
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Hepatitis B marker seropositivity in prostitutes using ELISA].
    Kiliç G; Ural O; Yaşayan Z
    Mikrobiyol Bul; 1993 Jan; 27(1):52-5. PubMed ID: 8421443
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of occult hepatitis B in high-risk populations in Kenya.
    Jepkemei KB; Ochwoto M; Swidinsky K; Day J; Gebrebrhan H; McKinnon LR; Andonov A; Oyugi J; Kimani J; Gachara G; Songok EM; Osiowy C
    PLoS One; 2020; 15(5):e0233727. PubMed ID: 32463824
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of circadian rhythm on the efficacy of the hepatitis B vaccination.
    Karabay O; Temel A; Koker AG; Tokel M; Ceyhan M; Kocoglu E
    Vaccine; 2008 Feb; 26(9):1143-4. PubMed ID: 18255201
    [No Abstract]   [Full Text] [Related]  

  • 40. Hepatitis B and human immunodeficiency virus infection in street youths in Toronto, Canada.
    Wang EE; King S; Goldberg E; Bock B; Milner R; Read S
    Pediatr Infect Dis J; 1991 Feb; 10(2):130-3. PubMed ID: 2062604
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.